Literature DB >> 9184423

A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.

W Nieuwenhuizen1.   

Abstract

The term "D-dimer assay" suggests, that these assays report the concentrations of the end-stage degradation product of crosslinked fibrin. This hardly occurs in patients. Degradation products of cross-linked fibrin rather occur with a wide range of molecular weights, and comprise various numbers of the D-dimer motif. Moreover, the numerical values obtained with different "D-dimer" assays vary widely. The variations are probably due to differences in reactivity of the various monoclonal antibodies used with the various D-dimer containing degradation products as they occur in patients; and to the various calibrators with a value assigned by the manufacturers. For the reasons indicated above a calibrator in the strict sense (e.g., pure D-dimer) is not feasible. This study shows that: it appears feasible to generate a conversion factor for each of the "D-dimer" assays studied, which will make the widely varying results obtained with these kits comparable; that the conversion factors can be based on a pool of real patient samples; and that the conversion factors are pool-independent. The next and final step in this study is to prepare and make available an international reference material for use by manufacturers and others facing a comparison problem. This is being carried out, in collaboration with the NIBSC (Dr. P. Gaffney), and the material is expected to be available in early 1997.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184423

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

Review 1.  Role of fibrin D-dimer testing in emergency medicine.

Authors:  A Wakai; A Gleeson; D Winter
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

2.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

3.  Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery.

Authors:  Akihiro Sudo; Hideo Wada; Tsutomu Nobori; Norikazu Yamada; Masaaki Ito; Rui Niimi; Masahiro Hasegawa; Koji Suzuki; Atsumasa Uchida
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

4.  Elevated levels of soluble fibrin in patients with venous thromboembolism.

Authors:  Akihiro Tsuji; Hideo Wada; Takeshi Matsumoto; Yasunori Abe; Satoshi Ota; Norikazu Yamada; Takashi Sugiyama; Akihiro Sudo; Katsuya Onishi; Kaname Nakatani; Atsumasa Uchida; Masaaki Ito; Koji Suzuki; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-10-04       Impact factor: 2.490

5.  Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis.

Authors:  Sally Bevan; Colin Longstaff
Journal:  J Thromb Haemost       Date:  2021-11-24       Impact factor: 16.036

6.  Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.

Authors:  Alexander E Kogan; Kadriya S Mukharyamova; Anastasia V Bereznikova; Vladimir L Filatov; Ekaterina V Koshkina; Marina N Bloshchitsyna; Alexey G Katrukha
Journal:  Blood Coagul Fibrinolysis       Date:  2016-07       Impact factor: 1.276

7.  From Hemophilia to Deep Venous Thrombosis Patient Samples: How to Perform an Easy Coagulometer Validation Process According to Available Guidelines.

Authors:  Silmara Aparecida de Lima Montalvão; Ana Paula Francisco; Bittar Letícia Queiroz da Silva; Stephany Cares Huber; Helder José Aguiari; Maria Carmem Gonçalves Lopes Fernandes; Priscila Soares Elidio; Beatriz de Moraes Martinelli; Isa Macedo Tony; Marina Pereira Colella; Joyce Maria Annichinno-Bizzachi
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

8.  Genetic predictors of fibrin D-dimer levels in healthy adults.

Authors:  Nicholas L Smith; Jennifer E Huffman; David P Strachan; Jie Huang; Abbas Dehghan; Stella Trompet; Lorna M Lopez; So-Youn Shin; Jens Baumert; Veronique Vitart; Joshua C Bis; Sarah H Wild; Ann Rumley; Qiong Yang; Andre G Uitterlinden; David J Stott; Gail Davies; Angela M Carter; Barbara Thorand; Ozren Polašek; Barbara McKnight; Harry Campbell; Alicja R Rudnicka; Ming-Huei Chen; Brendan M Buckley; Sarah E Harris; Annette Peters; Drazen Pulanic; Thomas Lumley; Anton J M de Craen; David C Liewald; Christian Gieger; Susan Campbell; Ian Ford; Alan J Gow; Michelle Luciano; David J Porteous; Xiuqing Guo; Naveed Sattar; Albert Tenesa; Mary Cushman; P Eline Slagboom; Peter M Visscher; Tim D Spector; Thomas Illig; Igor Rudan; Edwin G Bovill; Alan F Wright; Wendy L McArdle; Geoffrey Tofler; Albert Hofman; Rudi G J Westendorp; John M Starr; Peter J Grant; Mahir Karakas; Nicholas D Hastie; Bruce M Psaty; James F Wilson; Gordon D O Lowe; Christopher J O'Donnell; Jacqueline C M Witteman; J Wouter Jukema; Ian J Deary; Nicole Soranzo; Wolfgang Koenig; Caroline Hayward
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

Review 9.  Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation.

Authors:  Cheng Hock Toh; Yasir Alhamdi; Simon T Abrams
Journal:  Ann Lab Med       Date:  2016-11       Impact factor: 3.464

10.  The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.

Authors:  Jecko Thachil; Colin Longstaff; Emmanuel J Favaloro; Giuseppe Lippi; Tetsumei Urano; Paul Y Kim
Journal:  J Thromb Haemost       Date:  2020-09       Impact factor: 16.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.